Alpha Progression
Vitamin K2
Vitamin K2 is the collective name for a group of fat-soluble vitamin K compounds called menaquinones. They are identified by side-chain length, such as MK-4 or MK-7, and are not one interchangeable substance. Together with vitamin K1, K2 forms belong to the vitamin K family, which the body needs to activate proteins involved in normal blood clotting, bone metabolism, and other processes.
Vitamin K1, or phylloquinone, is the main dietary form and is abundant in green leafy vegetables and some plant oils. Menaquinones occur in varying amounts in fermented foods and some animal foods; gut bacteria also produce them, although the amount that contributes to human requirements is uncertain. Reference intakes generally apply to total vitamin K rather than prescribing a separate K2 target. Clinically important deficiency is uncommon in healthy adults but can occur with malabsorption or medicines that interfere with vitamin K.
The biological role of K2 does not by itself prove that an MK-4 or MK-7 supplement improves a health outcome. Vitamin K-dependent proteins occur in bone and blood vessels, but trials have not established that routine K2 supplementation prevents fractures, reverses arterial calcification, or improves strength-training results in generally healthy people. The NIH review of vitamin K describes mixed bone findings, limited cardiovascular trial evidence, and sparse comparisons between supplement forms. A change in a laboratory marker is not automatically the same as fewer fractures or cardiovascular events.
K2 is often marketed as a necessary partner for vitamin D3 or calcium. These nutrients do interact within bone and calcium physiology, but that does not create a blanket rule that everyone taking D3 must add K2. The relevant questions remain overall intake, clinical status, medications, and whether a specific deficiency or indication exists. Products should state the exact form and amount rather than merely listing "K2," because MK-4 and MK-7 have different pharmacokinetics and have been studied at different doses.
The most important safety issue is interaction with vitamin K-antagonist anticoagulants such as warfarin or phenprocoumon. Sudden changes in vitamin K intake from food or supplements can alter their effect; consistency and clinical supervision matter. Medicines that impair fat absorption and some prolonged antibiotic treatments can also affect vitamin K status. These interactions make self-prescribing a high-dose K2 product fundamentally different from eating a varied diet.
